So... you're saying that they spend millions of dollars on clinical trials, and then they abandon these products? Because there have been plenty of trials for non-invasive glucose meters -- unfortunately, they all fail horribly at producing consistently accurate readings.
And maybe this GoBe device IS an inconsistently accurate glucose meter?
What you're saying is this device already exists, but is not good enough for diabetes. But could it be good enough for dieting?
[1] http://www.masterthyself.com/wp-content/uploads/2012/12/Roll...
Anyways, I am thinking that these guys WILL deliver a device, but it won't be the miracle in technology everyone is expecting.
I would easily part with $1000 for a watch or anklet like accessory that would measure my glucose without it being possible for me to forget about it. And I'm not even the best target market for it, because my sugar has never gone low. I had a coworker with a child with type I diabetes and they had to test her sugar somewhere around 10x a day. I'm sure a lot of parents would part with even more money than I would to avoid having to prick their child 10x a day.
Edited to add: Actually, there are likely to be sophisticated electronics anyway, enough to have a timer. The only reason I can think of not to have a subscription based model (i.e. it will work for 1 year for $250) is that it might turn off more potential customers and overall revenue could be reduced.
As others have said, non invasive monitoring is the holy grail and huge amounts of money are looking for a non invasive solution. But innovation here is likely to come from a start up that doesn't have the existing recurrent revenue model to be disrupted
But it's really hard. I think the chances of this particular one being a scam are pretty high
It's more like the "manager's dilemma".
Christensen suggests that successful companies can put too much emphasis on customers' current needs, and fail to adopt new technology or business models that will meet customers' unstated or future needs; he argues that such companies will eventually fall behind
I've been talking with a Gerontologist doctor who has been actively monitoring patients with diabetes in my town. She is an incredibly up-to-date doctor. She told me that any kind of therapy or approach that doesn't bring $$$ back to the pharmaceutical companies (involving long term treatment with supplies) is immediately abandoned. Research from major players is money-driven and nothing more. She mentioned a couple of cases which I can't recall.
I have high hopes for this project and for Google's Contact Lens[1]. Let's hope it flies...
[1] http://www.sci-tech-today.com/story.xhtml?story_id=12300CTY4...